Cargando…

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Chimeric antigen receptor T-cell therapy (CART) has extended survival of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL). However, limited durability of response and prevalent toxicities remain problematic. Identifying patients who are at high risk of disease progression, tox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shouse, Geoffrey, Kaempf, Andy, Gordon, Max J., Artz, Andy, Yashar, David, Sigmund, Audrey M., Smilnak, Gordon, Bair, Steven M., Mian, Agrima, Fitzgerald, Lindsey A., Bajwa, Amneet, Jaglowski, Samantha, Bailey, Neil, Shadman, Mazyar, Patel, Krish, Stephens, Deborah M., Kamdar, Manali, Hill, Brian T., Gauthier, Jordan, Karmali, Reem, Nastoupil, Loretta J., Kittai, Adam S., Danilov, Alexey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Clinical Trials and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362276/ https://www.ncbi.nlm.nih.gov/pubmed/36735393 http://dx.doi.org/10.1182/bloodadvances.2022009309

Ejemplares similares

A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
por: Gordon, Max J., et al.
Publicado: (2023)

TRES, a validated three-factor comorbidity score, is associated with survival in older patients with mantle cell lymphoma
por: Gordon, Max J., et al.
Publicado: (2023)

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
por: Epperla, Narendranath, et al.
Publicado: (2023)

The case of a 40‐year‐old man with headaches, memory changes, and acute ischemic stroke
por: Smilnak, Gordon, et al.
Publicado: (2021)

Calciphylaxis of the penis and distal digits: a case report
por: Smilnak, Gordon, et al.
Publicado: (2022)

Thoracic sarcoidosis versus tuberculosis: Need for a multi-disciplinary approach
por: Mian, Agrima, et al.
Publicado: (2018)

Vaccinations in CLL: implications for COVID-19
por: Shadman, Mazyar, et al.
Publicado: (2021)

Improving Outcomes for Patients With Chronic Lymphocytic Leukemia
por: Shadman, Mazyar, et al.
Publicado: (2020)

Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab
por: Lopedote, Paolo, et al.
Publicado: (2023)

Hematopoietic Cell Transplantation for Older Patients with MDS
por: Shadman, Mazyar, et al.
Publicado: (2014)

Childhood trauma fatality and resource allocation in injury control programs in a developing country
por: Roudsari, Bahman S, et al.
Publicado: (2006)

Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
por: Schaefer, Andrew, et al.
Publicado: (2021)

Redesigning library orientation for first-year medical students during the pandemic
por: Hickner, Andy, et al.
Publicado: (2021)

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL
por: Zurko, Joanna, et al.
Publicado: (2022)

Comorbidity of age-related macular degeneration with Alzheimer’s disease: A histopathologic case-control study
por: Smilnak, Gordon J., et al.
Publicado: (2019)

Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
por: Oncale, Melody B, et al.
Publicado: (2017)

Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives
por: Munoz, Javier, et al.
Publicado: (2021)

Fifty‐eight‐year‐old female with abdominal migraine: A rare cause of episodic gastrointestinal disturbance in adults
por: Karmali, Rehan, et al.
Publicado: (2020)

Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
por: Al Rabadi, Luai S., et al.
Publicado: (2021)

Impact of TP53 mutations in Triple Negative Breast Cancer
por: Mitri, Zahi I., et al.
Publicado: (2022)

Experimental modulation of external microbiome affects nestmate recognition in harvester ants (Pogonomyrmex barbatus)
por: Dosmann, Andy, et al.
Publicado: (2016)

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
por: West, Malinda T, et al.
Publicado: (2023)

Current overview and treatment of mantle cell lymphoma
por: Schieber, Michael, et al.
Publicado: (2018)

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient
por: Hill, Joshua A., et al.
Publicado: (2021)

P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY
por: Sehn, Laurie H., et al.
Publicado: (2023)

Anomaly Detection using Machine Learning for Data Quality Monitoring in the CMS Experiment
por: Seth, Agrima
Publicado: (2017)

COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
por: Shadman, Mazyar, et al.
Publicado: (2022)

NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells
por: Kittai, Adam S., et al.
Publicado: (2021)

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
por: Matasar, Matthew J., et al.
Publicado: (2019)

Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia
por: Samuels, Courtney, et al.
Publicado: (2021)

Coverslip scrape cytology (CSSC): Novel technique for OSSN diagnosis
por: Bhatia, Agrima, et al.
Publicado: (2023)

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
por: Budde, Lihua E., et al.
Publicado: (2022)

Host metabolome predicts the severity and onset of acute toxicities induced by CAR T-cell therapy
por: Jalota, Akansha, et al.
Publicado: (2022)

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar
por: Courville, Jocelyn, et al.
Publicado: (2021)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
por: Gunther, Jillian R., et al.
Publicado: (2020)

A Missed Diagnosis of Ovarian Torsion in a Patient with Bilateral Ovarian Dermoid Cysts: A Case Report
por: Ghosh, Agrima, et al.
Publicado: (2019)

Exploring Risk Factors for Follicular Lymphoma
por: Ambinder, Alexander J., et al.
Publicado: (2012)

Antiepidermal Growth Factor Receptor Monoclonal Antibodies: Applications in Colorectal Cancer
por: Azizi, Efat, et al.
Publicado: (2012)

Racial/ethnic, gender, and age group differences in cardiometabolic risks among adults in a Northern California health plan: a cross-sectional study
por: Gordon, Nancy P., et al.
Publicado: (2021)

Phenoxythiophene sulfonamide compound B355252 protects neuronal cells against glutamate-induced excitotoxicity by attenuating mitochondrial fission and the nuclear translocation of AIF
por: Zhang, Yuxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_090vemfa1kah3k2oq52plfph8g